BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma using Functional Respiratory Imaging

Trial Identifier: D3250R00107
Sponsor: AstraZeneca
NCTID:: NCT05552508
Start Date: November 2022
Primary Completion Date: September 2023
Study Completion Date: November 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Box Hill, AU, 3128
AU Clayton, AU, 3168
AU Frankston, AU, 3199
AU Toorak Gardens, AU, 5065
BE Liege, BE, 4000
BE Mechelen, BE, 2800
BE Montigny-le-Tilleul, BE, 6110
BE Namur, BE, 5101
BE Roeselare, BE, 8800
ES Alzira, ES, 46410
ES Barcelona, ES, 8003
ES Barcelona, ES, 08006
ES Madrid, ES, 28007
ES Santander, ES, 39008
ES Villarreal (Castellón), ES, 12540
FR Bordeaux, FR, 33076
FR Caen, FR, F-14033
FR Cannes, FR, 06414
FR Clermond Ferrand, FR, 63003
FR Libourne Cedex, FR, 33505
FR Montpellier Cedex 5, FR, 34295
GB Bradford, GB, BND9 6RJ
GB Nottingham, GB, NG5 1PB
GB St Just, GB, TR19 7HX
PT Lisboa, PT, 1649-035
PT Lisboa, PT, 1349-019
PT Porto, PT, 4100-180
US, CA Walnut Creek, CA, US, 94598
US, CO Denver, CO, US, 80206
US, FL Loxahatchee, FL, US, 33470
US, FL Plantation, FL, US, 33324
US, IN Greenwood, IN, US, 46143
US, KY Lexington, KY, US, 40536
US, KY Lexington, KY, US, 40502
US, MA Springfield, MA, US, 01199
US, Missouri Saint Louis, Missouri, US, 63110
US, MO Saint Louis, MO, US, 63110
US, PA Du Bois, PA, US, 15801
US, TN Knoxville, TN, US, 37909
US, TX Tyler, TX, US, 75708
US, TX Webster, TX, US, 77598
US, VA Charlottesville, VA, US, 22908